Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study

BACKGROUND: Acute respiratory distress syndrome (ARDS) is caused by rapid-onset (within hours) acute inflammatory processes in lung tissue, and it is a life-threatening condition with high mortality. The treatment of ARDS to date is focused on the prevention of further iatrogenic damage of the lung...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Haeberle, Helene, Prohaska, Stefanie, Martus, Peter, Straub, Andreas, Zarbock, Alexander, Marx, Gernot, Zago, Manola, Giera, Martin, Koeppen, Michael, Rosenberger, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057516/
https://ncbi.nlm.nih.gov/pubmed/32131881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-4163-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados